Related Experiment Videos
Immune response to three doses of quadrivalent rotavirus vaccine: 1-year follow-up
1Instituto de Biomedicina, Universidad Central de Venezuela, Caracas, Venezuela.
Insights
This study evaluated the quadrivalent rotavirus vaccine in children. The vaccine demonstrated effectiveness in boosting antibody levels and preparing children against severe rotavirus diarrhea.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Rotavirus is a leading cause of severe diarrheal disease in children globally.
- Vaccination is a key strategy for preventing rotavirus infections.
Purpose of the Study:
- To assess the immunogenicity and efficacy of a quadrivalent rotavirus vaccine in children.
- To evaluate antibody responses following a three-dose vaccination schedule.
Main Methods:
- Twenty-eight children received three doses of the quadrivalent rotavirus vaccine (4 x 10(5) p.f.u.).
- Serum samples were analyzed for rotavirus IgA and neutralizing antibodies.
- Antibody levels were measured before and after vaccination over one year.
Main Results:
- Up to 61% of children showed increased circulating IgA antibody levels.
- Nearly all children developed increased neutralizing antibodies against vaccine strains.
- 25-54% of children showed increased neutralizing antibodies against human rotavirus serotypes.
Conclusions:
- Three doses of the quadrivalent rotavirus vaccine (4 x 10(5) p.f.u.) induce significant antibody responses.
- The vaccine appears to prepare children against severe rotavirus diarrhea, particularly against serotype G1.
Abstract:
Twenty-eight children who received three doses of the quadrivalent rotavirus vaccine with 4 x 10(5) plaque-forming units (p.f.u.) were followed during a year after vaccination. Serum samples were obtained and evaluated for rotavirus IgA and neutralizing antibodies against vaccine and human rotavirus strains. At the end of the study, up to 61% of the children showed an increase in circulating IgA antibody levels. Nearly all of the vaccinated children increased their neutralizing antibody titres against the vaccine strains, and 25-54% against human rotavirus serotypes. After comparing the vaccinees with a population of children naturally infected with serotype G1 in the same study area, we conclude that three doses of 4 x 10(5) p.f.u. of the quadrivalent vaccine should prepare the child against future severe rotavirus diarrhea.